An Antibody to De-N-Acetyl Sialic Acid Containing-Polysialic Acid Identifies an Intracellular Antigen and Induces Apoptosis in Human Cancer Cell Lines by Steirer, Lindsay M. & Moe, Gregory R.
An Antibody to De-N-Acetyl Sialic Acid Containing-
Polysialic Acid Identifies an Intracellular Antigen and
Induces Apoptosis in Human Cancer Cell Lines
Lindsay M. Steirer
1, Gregory R. Moe
1,2*
1Centers for Cancer, Children’s Hospital Oakland Research Institute (CHORI), Oakland, California, United States of America, 2Immunobiology and Vaccine Development,
Children’s Hospital Oakland Research Institute (CHORI), Oakland, California, United States of America
Abstract
Polysialic acid (PSA), an a2,8-linked homopolymer of N-acetylneuraminic acid (Neu5Ac), is developmentally regulated and its
expression is thought to be restricted to a few tissues in adults. Recently, we showed that two human pathogens expressed
a derivative of PSA containing de-N-acetyl sialic acid residues (NeuPSA). Here we show that an epitope identified by the
anti-NeuPSA monoclonal antibody, SEAM 3 (SEAM 3-reactive antigen or S3RA), is expressed in human melanomas, and also
intracellularly in a human melanoma cell line (SK-MEL-28), a human T cell leukemia cell line (Jurkat), and two neuroblastoma
cell lines (CHP-134 and SH-SY5Y). SEAM 3 binding induced apoptosis in the four cell lines tested. The unusual intracellular
distribution of S3RA was similar to that described for the PSA polysialyltransferases, STX and PST, which are also expressed
in the four cell lines used here. Interestingly, suppression of PST mRNA expression by transfection of SK-MEL-28 cells with
PST-specific short interfering RNA (siRNA) resulted in decreased SEAM 3 binding. The results suggest further studies of the
utility of antibodies such as SEAM 3 as therapeutic agents for certain malignancies.
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Introduction
PSA modification appears to be limited to a few animal proteins
and the capsular polysaccharides of the neuroinvasive bacteria
Neisseria meningitidis group B (NmB) and E. coli K1 [1]. In humans,
PSA has been shown to be present on neural cell adhesion
molecule (NCAM) [2], synaptic cell adhesion molecule 1 [3], the
alpha subunit of the voltage sensitive sodium channel [4], the
integrin alpha 5 subunit [5] the scavenger receptor CD36 [6],
neuropilin-2 [7], and the PSA polysialyltransferases ST8Sia2 and
ST8Sia4, also known as STX and PST, respectively [8]. NCAM is
the most abundant polysialylated protein, especially during fetal
development, and the role of polysialylation in NCAM function is
the most thoroughly investigated [9]. NCAM polysialylation
blocks the adhesive properties of NCAM to allow cell migration
and modulate other NCAM functions [9]. In adult mice, PSA
expression is limited to a few tissues in the brain that exhibit
synaptic plasticity such as the olfactory bulb and hypothalamus [9]
and may have a role in T cell development [10]. Some human
tumors, including astrocytoma [11], small cell and non-small cell
lung carcinoma [12], multiple myeloma [13], neuroblastoma [14],
rhabdomyosarcoma [15] and Wilms’ tumor [16] express PSA and
the relative level of PSA expression in some cancers has been
associated with poor prognosis [12,17].
During the development of vaccines for the prevention of
disease caused by NmB, we discovered that a murine monoclonal
antibody (mAb) SEAM 3, which was produced by immunization
with an N-propionyl derivative NmB capsular polysaccharide (N-
Pr MBPS)-based vaccine [18], recognized PSA antigens that
contained de-N-acetylated neuraminic acid (Neu) residues
[19,20,21]. The presence of Neu residues in the N-Pr MBPS-
tetanus toxoid vaccine was an unintended side product resulting
from incomplete re-N-acylation. Subsequently, we showed that
neuraminic acid-containing PSA (NeuPSA), including fully de-N-
acetylated PSA, was immunogenic and elicited antibodies that
were protective against NmB and NmC strains [19].
Although NeuPSA had not been described previously in
humans, shorter Neu-containing sialic acid antigens (NeuSia),
such as gangliosides had been reported to be present in some
human tumors and cancer cell lines [22,23,24]. NeuSia antigens
expressed in human tumors include NeuSia variants of the mono-
and disialylogangliosides GM3 and GD3 [22,23,24,25,26],
respectively. Hakomori and coworkers showed that NeuSia GD3
expressed in the human epithelial carcinoma cell line A431 was a
strong activator of epidermal growth factor receptor kinase in
Triton X-100-treated cells [27,28]. The result suggests that the
NeuSia GM3 derivative may have a role in activating receptor
pathways that promote cell proliferation. Using radioactive
labeling experiments in melanoma cell lines, Varki and coworkers
showed that N-acetyl groups in gangliosides GD3 and GM3
turned over more rapidly than the parent molecules, suggesting
the existence of NeuSia-containing gangliosides in these cells [25].
PLoS ONE | www.plosone.org 1 November 2011 | Volume 6 | Issue 11 | e27249Recently, Popa et al isolated and structurally characterized
NeuSia-containing GD3 from primary human melanoma tumors
[26]. Since some cancer cells express NeuSia antigens, it raised the
question of whether the longer NeuPSA-modified antigens are also
expressed by human cancer cells. In the following, we investigated
the reactivity of SEAM 3 with normal human skin, primary
human melanoma tumors and several human cancer cell lines
including leukemia, melanoma, and neuroblastoma cells, and the
functional activity of SEAM 3 against these cancer cell lines.
Results
Specificity of mAb SEAM 3
We have previously shown that SEAM 3 is reactive with a
variety of Neu-containing oligosialic acid (OSA)/PSA derivatives
[18,19,20]. To define the specificity of SEAM 3 with respect to
NeuOSA/PSA antigens likely to be expressed naturally (ie. N-
acetyl-containing derivatives), we prepared partially de-N-acety-
lated derivatives of OSA by mild base treatment of purified
oligosaccharides having a degree of polymerization (DP) of 2, 3,
and 4. The average amount of Neu was determined using a
modified resorcinol assay that can measure the amount of
neuraminic acid (Neu) and N-acetylneuraminic acid (Neu5Ac) in
PSA [19]. After mild base treatment, the oligosaccharides
contained ,25% Neu and there was some degradation of the
longer oligosaccharides such that the trimer contained both dimers
and trimers and the tetramer contained dimers, trimers and
tetramers. The relative ability of the oligosaccharides to inhibit
binding of SEAM 3 to the nominal N-Pr MBPS antigen was
determined by ELISA. The results are summarized in Table 1.
The concentrations of oligosaccharide required to inhibit SEAM 3
binding represent upper limits since the preparations contain a
mixture of shorter oligosaccharides in addition to the longest one
indicated by DP. Also, the number given for DP does not take into
account the possible effect of reducing the C2 carbonyl group
of the reducing end residue, which is necessary to prevent
degradation during base treatment. Given these considerations,
oligosaccharides having a DP of 4 were the best inhibitors of
SEAM 3 binding. The ability of the oligosaccharides to inhibit
SEAM 3 binding was not affected by incubating them at pH 5
without or with exoneuraminidase at 37uC for 48 hours (data not
shown). The treatments enrich the oligosaccharides for chains that
have Neu at the non-reducing end [19]. SEAM 3 binding was not
inhibited by closely related MCPS (ie. poly a2,9 N-acetylneur-
aminic acid) either when fully N-acetylated or containing de-N-
acetylated residues (Table 1). Taken together, we conclude that
SEAM 3 recognizes oligo or polysialic acid derivatives having a
DP of 4 or greater, where approximately every fourth residue is
Neu, which may be located at the non-reducing end or at internal
positions of the polymer (Figure 1).
Immunohistochemical (IHC) staining of normal human
skin and primary melanoma tumors
In normal tissues, de-N-acetyl GD3 was reported to be
expressed ‘‘at low levels in few blood vessels, infiltrating
mononuclear cells of the skin and colon and at moderate levels
in skin melanocytes’’ [22]. Higher levels were expressed in
melanomas [22]. PSA-NCAM is widely expressed in endodermal,
mesodermal, ectodermal and neuro-ectodermal derived tissues at
various stages of fetal development, but expression in adults is
limited to a few areas of the brain exhibiting neuro-plasticity [29].
To determine whether antigens reactive with SEAM 3 were
expressed in normal human skin and primary melanomas, we
performed IHC on frozen and formalin-fixed paraffin embedded
tissue specimens. The mAb R24 was used to mark GD3.
Chammas et al., have reported that formalin treatment of tissue
samples can result in modification of de-N-acetyl GD3 amino
groups with formaldehyde, resulting in loss of reactivity with anti-
de-N-acetyl GD3 mAbs [22]. Also, IHC staining for the presence
of GD3 in formalin-fixed paraffin embedded tissues specimens has
been described as being sensitive to loss of anti-GD3 reactivity as a
result of antigen recovery procedures [30]. We found the
respective staining patterns observed for each mAb tested were
similar irrespective of which method was used to prepare the
specimens, except that staining was decreased to some extent in
frozen, unfixed specimens compared to paraffin embedded,
formalin-fixed tissues. Also, it was more difficult to obtain large,
unbroken sections of tissue in the unfixed specimens. Since fixing
the specimens resulted in superior preservation of the tissue
structure and greater sensitivity of staining, only the results
obtained using fixed tissues are shown.
IHC staining of fixed normal human skin shows that SEAM 3
marks cells of the squamous epithelium and infiltrating lympho-
cytes (Figure 2A), while the negative control irrelevant murine
IgG2b and IgG3 mAbs showed no reactivity. In contrast, the anti-
Table 1. Inhibition of SEAM 3 binding by Neu-containing PSA
oligosaccharides.









32 5 1 . 9
2 ,10 .200
22 5 5 1






aThe lower limit of detection is ,10% Neu in the resorcinol assay.
bConcentration of inhibitor required to inhibit 50% of binding of SEAM 3 to the
nominal N-Pr MBPS antigen by ELISA. For comparison, the nominal N-Pr MBPS
antigen (DP.30, 16% Neu) used to produce SEAM 3 had an IC50 value of
0.01 mg/ml. The concentrations of purified SEAM 3 used in the ELISA were
0.07 mg/ml.
doi:10.1371/journal.pone.0027249.t001
Figure 1. Minimal NeuPSA epitope recognized by SEAM 3 as
determined by inhibition ELISA with NeuPSA derivatives
(Table 1).
doi:10.1371/journal.pone.0027249.g001
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melanocytes in normal skin (Figure 2A, example indicated by
arrow). SEAM 3 staining appeared to be largely cytoplasmic with
a distinctive granular appearance. SEAM 3 binding to antigens
present in normal skin could be inhibited by greater than 90%
when the mAb was pre-incubated with N-Pr MBPS (50 mg/ml).
N-Pr MBPS is the polysaccharide antigen used to produce SEAM
3 [18]. The result shows that SEAM 3 binding was mediated by
the antibody combining site.
The dark staining of the melanoma specimen resulting from
SEAM 3 binding (Figure 2B) shows that S3RA antigens were
expressed in the tumor. As with normal skin, SEAM 3 binding to
antigens in the melanoma specimen was inhibited with soluble N-
Pr MBPS (Figure 2B). The intense staining of the melanoma
specimen suggests that S3RA was expressed at higher levels in the
tumor compared to normal epithelial cells. All tumor cells within
the section, which had dimensions of approximately 1 cm62 cm,
were stained. In contrast, the anti-GD3 mAb exhibited heteroge-
neous binding to the tumor tissue with some cells marked by the
mAb while others showed no staining (Figure 2B).
In addition to the example primary human melanoma shown in
Figure 2B, an array of 12 smaller primary human melanoma
specimens taken from skin, esophageal, parotid, and rectal tumors
were evaluated for SEAM 3 and irrelevant IgG2b reactivity by
IHC. All the melanoma specimens in the array were reactive with
SEAM 3 while the irrelevant IgG2b mAb showed no reactivity
(data not shown). The intensity of staining resulting from SEAM 3
binding in the melanoma tumor array was similar to the example
shown in Figure 2B. Samples of normal skin taken from areas
adjacent to some of the melanomas that were included in the
specimen array exhibited the same pattern of SEAM 3 reactivity as
that shown in Figure 2A with normal skin (data not shown).
Expression of S3RA in cancer cell lines
Since the de-N-acetyl sialic acid-containing derivative of the
disialyloganglioside GD3 has been reported to be present in
melanoma cell lines [24] as well as in primary human tumors [26]
and we found that SEAM 3 was reactive with primary melanomas
(Figure 2B), we performed flow cytometry to measure SEAM 3
binding with four human cancer cell lines that express different
Sia-containing antigens (Table 2).
Figure 3 shows binding of the subclass-matched irrelevant mAb
IgG2b compared to SEAM 3, the anti-GD3 mAb R24 and anti-
NCAM (CD56) mAb binding to SK-MEL-28 melanoma and SH-
SY5Y neuroblastoma cells in the absence and presence of Triton
X-100 treatment, as indicated. Gates defining cells as positive for
binding were set using subclass matched isotype controls and are
indicated on each histogram shown in Figure 3. In the absence of
detergent, 29% of SK-MEL-28 cells were positive for SEAM 3
binding compared to 80% for anti-GD3 and 3% for the irrelevant
mAb. However, when the cells were made permeable to the mAbs
by detergent treatment, 82% of the SK-MEL-28 cells were
positive for SEAM 3 binding and the relative fluorescence
increased more than 10-fold. The percent of anti-GD3 positive
cells increased slightly to 92%. Binding of the anti-NCAM mAb
was comparable to the irrelevant IgG1 mAb in the presence or
absence of detergent and, therefore, N-CAM was not expressed in
SK-MEL-28 cells. For the SH-SY5Y cell line, 20% of the non-
detergent treated cells were positive for SEAM 3 binding, which
increased to 96% in the presence of detergent (Figure 3). Also, the
relative fluorescence increased by more than 10-fold. Greater than
85% of SH-SY5Y cells were positive for anti-NCAM and less than
21% for anti-GD3 binding in both intact or permeabilized cells.
The results summarized in Table 3 for the four cell lines show that
the percent of cells positive for SEAM 3 binding and the mean
fluorescence of the cells was variable among the cell lines tested.
Figure 2. NeuPSA is expressed in normal human skin and in
primary melanoma tumors. IHC analysis of SEAM 3 and anti-GD3
binding to normal human skin (A) and a primary melanoma (B).
Formalin-fixed normal human skin (A) and primary melanoma (B) were
incubated with irrelevant IgG2b, SEAM 3, SEAM 3 with a polysaccharide
inhibitor N-Pr MBPS, irrelevant IgG3, and anti-GD3 mAb R24 as
indicated. Binding was detected using DAB, which produces a brown
precipitate. Counterstaining was performed using hemotoxylin. The
arrow in the micrograph of SEAM 3 binding to normal skin shows an
example of SEAM 3 marking an infiltrating lymphocyte and for the anti-
GD3 micrograph, a melanocyte. Reference bars=40 mm.
doi:10.1371/journal.pone.0027249.g002
Table 2. Expression of PSA-NCAM and GD3 in human cancer
cell lines tested.
Sia antigen Cell line
SK-MEL-28 Jurkat CHP-134 SH-SY5Y
PSA-NCAM 22
a ++ [42]
GD3 + [43] 2 + 2
aRecent studies have suggested that Jurkat cells may transiently express GD3
during Fas (CD95)-signaling [44] and normal human leukocytes have been
shown to express PSA-NCAM [10].
doi:10.1371/journal.pone.0027249.t002
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SEAM 3 binding. In contrast, nearly all cells of each cell line
contained intracellular SEAM 3-reactive antigens (S3RA). The
predominant intracellular distribution of S3RAs did not corre-
spond to the distribution of GD3 or PSA-NCAM, which were
mainly localized on the cell surface. The result suggests that
S3RAs were not de-N-acetyl Sia derivatives of either GD3 or PSA-
NCAM or that the intracellular counterparts of these molecules
were not reactive with the respective mAbs.
To demonstrate specificity of binding, fixed and permabolized
Jurkat or SK-MEL-28 cells were incubated with SEAM 3 in the
absence and presence of the N-Pr MBPS inhibitor. Unlike the
fixed tissue specimens however, the relatively high concentrations
of SEAM 3 (5 mg/ml) in combination with the soluble N-Pr MBPS
inhibitor produced ambiguous results. In some experiments partial
inhibition was observed but in others the polysaccharide inhibitor
had either no effect or resulted in an increase in binding. It is
possible that the variable effects of adding N-Pr MBPS to the
binding reaction resulted from the propensity of NeuPSA
derivatives present in the N-Pr MBPS preparation to form
aggregates that are too large to escape the permeablized cells or
that the cells have receptors for NeuPSA that also bind to N-Pr
MBPS.
Fluorescence microscopy. Immuno-fluorescence microscopy
(IFM) was used to further investigate the cellular location of SEAM
3-reactive epitopes in detergent untreated and treated SK-MEL-28
and CHP-134 cells (Figure 4). The results of flow cytometry binding
experiments with SK-MEL-28 cells not treated or treated with
detergent (Figure 3) suggested that SEAM 3 reactive epitopes had a
cellular localization that was different from GD3 and PSA-NCAM.
Consistent with these results, only a subset of SK-MEL-28 and
CHP-134 cells not treated with detergent were reactive with SEAM
Figure 3. Intracellular localization of de-N-acetyl PSA in melanoma and neuroblastoma cell lines. SK-MEL-28 and SH-SY5Y cells were
either untreated to detect surface binding (upper panel in each set of two panels), or treated with Triton-X 100 to detect intracellular binding (lower
panel) by flow cytometry. Cells were incubated with 5 mg/ml of each primary antibody, followed by incubation with 2 mg/ml Alexa Fluor 488-
conjugated secondary antibody. Irrelevant murine IgG2b, IgG3, and IgG1 mAbs were used as negative controls for SEAM 3, anti-GD3, and anti-NCAM,
respectively, and were used to determine baseline fluorescence. Binding was detected using Guava EasyCyte flow cytometer. Gates used to define
cells positive for binding are indicated at the top of each histogram.
doi:10.1371/journal.pone.0027249.g003
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MEL-28 cells that were most reactive with SEAM 3 were ‘‘rounded
up’’ cells with relatively condensed nuclear DNA as shown by DAPI
staining. Elongated cells were less reactive with SEAM 3 (compare
SK-MEL-28 cells in light micrograph shown in Figure 4 with IFM).
In contrast, anti-GD3 labeled all cells (green fluorescence as
indicated in Figure 4). However, when the SK-MEL-28 cells were
treated with detergent, all cells were positive for SEAM 3 binding
(Figure 4). In the detergent-treated cells, SEAM 3 reactivity was
dispersed throughout the cytoplasm in granule-like structures
(Figure 4, example indicated by an arrow). Anti-GD3 reactivity
was characterized by a diffuse pattern of staining with spots of
concentrated reactivity in both untreated and detergent-treated cells
(Figure 4). There was some degree of co-localization evident in
composite images of SEAM 3 and anti-GD3-labled cells (yellow in
Figure 4) but clear differences as well. Thus, SEAM 3 reactivity was
not directly correlated with GD3 other than incidental localization
to the membrane in the absence or presence of detergent and
expression of S3RAs was limited to a subset of cells.
In CHP-134 cells, SEAM 3-reactive epitopes (red fluorescence
in Figure 4 CHP-134 cells as indicated) were mainly localized to
borders of contact between cells. PSA antigens, as detected with
the anti-PSA mAb 2-1-B [31] (green fluorescence in Figure 4 as
indicated), were also located mainly in regions of cell-cell contact.
Although the fluorescence resulting from SEAM 3 binding was
lower, both the relative intensity and distribution of fluorescence
resulting from anti-PSA binding was similar to that of SEAM 3 in
intact cells as shown by the yellow color resulting from
superposition of red and green fluorescence in the composite
image (Figure 4). This was indicative of the SEAM 3-labeled
antigen being located on the cell surface. Moreover, SEAM 3
labeling was correlated with anti-PSA labeling (Manders’ coeffi-
cient for green=0.998) and to a lesser extent with anti-NCAM
labeling (Manders’ coefficient for green=0.642; micrographs not
shown) in either the absence or presence of Triton X-100.
However, when the cells were treated with detergent there was less
overlap between SEAM 3 and anti-PSA labeling (indicated by
relatively larger amount of red fluorescence in the detergent
treated composite micrograph) suggesting that there was a fraction
of antigens recognized by the mAbs in common and distinct
antigens recognized separately.
Since in SK-MEL-28 cells the majority of antigens reactive with
SEAM 3 were located in granular like structures inside cells, we
performed IFM using markers for the Golgi and endoplasmic
reticulum (ER) to determine whether SEAM 3 reactivity was
associated with those particular subcellular organelles. Golgi
markers included giantin and golgin-97 for cis/medial and trans
Golgi membranes, respectively, and Tuba, a multifunctional
protein thought to be involved in regulating cell junction and
endocytic trafficking [32] of Golgi-derived vesicles in the
cytoplasm [33]. Calnexin, a molecular chaperone protein was
used as an ER marker [34]. As shown by the presence or lack of
yellow fluorescence in composite images, SEAM 3 was substan-
tially co-localized with the Golgi and ER (as indicated in Figure 4)
markers. Co-localization was analyzed further using JACoP [35]
in Image J. All of the Golgi and ER markers were found to have
high colocalization for the marker versus SEAM 3 (Manders’
coefficients for green all greater than 0.92) with obvious
distribution of S3RAs outside of the organelles as well. The
closest overall colocalization was between SEAM 3 and Tuba as
shown in Figure 4. Thus, NeuPSA antigens detected using SEAM
3 were mainly located inside cells and associated with the Golgi,
ER and cellular matrix, but were also present on the surface of
subpopulations of each cell line.
Expression of polysialyltransferases PST and STX in
cancer cell lines
The neuroblastoma cell lines CHP-134 and SH-SY5Y were
known to express high levels of PSA in the form of PSA-NCAM,
while Jurkat and SK-MEL-28 cells were not known to express PSA
or NCAM. Since NeuPSA is likely to be derived from PSA, we
measured the expression of the a2,8 polysialyltransferases ST8Sia2
(STX) and ST8Sia4 (PST) mRNA in the four cell lines by
quantitative PCR. SH-SY5Y cells have been shown to express
both STX and PST [36], and were used for comparison of STX
and PST expression in the other cell lines. Using absolute
quantification, we determined STX expression was highest in SH-
SY5Y cells, with 1.2610
6 copies/1610
7 copies of GAPDH
(Figure 5). CHP-134 expressed similar levels of STX, while SK-
MEL-28 cells expressed nearly 100-fold less and Jurkat cells
expressed nearly 1000-fold less STX. SH-SY5Y cells expressed the
least amount of PST compared to the other three cells lines, with
9.0610
2 copies/1610
7 copies GAPDH. CHP-134, SK-MEL-28,
and Jurkat cells expressed 60, 140, or 550-fold more PST,
respectively, compared to SH-SY5Y cells (Figure 5).
Dependence of SEAM 3 reactivity with SK-MEL-28 cells
on the expression of polysialyltransferase PST
To establish that SEAM 3 is reactive with an antigen that is
derived from PSA, we investigated whether inhibiting the
expression of polysialyltransferase PST mRNA in SK-MEL-28
cells with PST-specific small interfering RNA (siRNA) would
result in a decrease in SEAM 3-positive cells by flow cytometry.
Negative control scrambled siRNA or PST specific-siRNA was
transfected into SK-MEL-28 cells and after 72 hours, the relative
quantity (RQ) of PST present was significantly decreased
(P,0.0001) in the cells transfected with PST siRNA
(RQ=0.124) compared to cells transfected with negative control
siRNA (RQ=1) (Figure 6).
In this experiment, only the subset of cells transfected with
the siRNA and depleted of pre-existing PSA derivatives would
be expected to show deceased reactivity with SEAM 3 if the
antigen reactive with the mAb was dependent on the activity of
PST. Despite these limitations, in three separate experiments
Table 3. Summary of SEAM 3 binding to cancer cell lines
determined by flow cytometry.
Cell line Percent positive (geometric mean fluorescence)
Jurkat IgG2b SEAM 3 Anti-GD3 Anti-NCAM
2Triton X-100 5 (3) 16 (5) 8 (3) 6 (3)
+Triton X-100 3 (3) 95 (74) 57 (12) 1 (2)
SK-MEL-28
2Triton X-100 3 (4) 29 (8) 80 (73) 6 (5)
+Triton X-100 6 (5) 82 (65) 92 (113) 5 (4)
CHP-134
2Triton X-100 5 (5) 25 (15) 64 (48) 85 (169)
+Triton X-100 4 (3) 93 (118) 91 (92) 83 (29)
SH-SY5Y
2Triton X-100 4 (4) 20 (9) 10 (8) 85 (238)
+Triton X-100 3 (3) 96 (148) 21 (4) 87 (39)
doi:10.1371/journal.pone.0027249.t003
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cells was significantly decreased in cells transfected with PST
siRNA compared to cells transfected with scrambled siRNA
(Table 4). The result clearly shows that antigens recognized by
SEAM 3 in SK-MEL-28 cells were dependent on the expression of
PST.
Figure 4. Immuno-fluorescence analysis of SEAM 3 binding to human SK-MEL-28 melanoma and CHP-134 neuroblastoma cells.
Light micrographs of SK-MEL-28 and CHP-134 show the general shape of cells with nuclear DNA indicated in blue. Anti-NeuPSA mAb SEAM 3 binding
(in red) to SK-MEL-28 and CHP-134 cells not treated or treated with Triton X-100 to permeablize the cells, was compared to anti-GD3 and –PSA in
green, as indicated. Subcellular localization of S3RA in SK-MEL-28 cells with Golgi (giantin, golgin 97 and Tuba) and ER (calnexin) markers are shown in
the bottom panel in yellow. Arrows indicate granular vesicular-like structures with relatively intense SEAM 3 staining. Reference bars=20 mm.
doi:10.1371/journal.pone.0027249.g004
De-N-Acetyl Sialic Acid Antibody
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cells
The function of S3RA in cells is unknown. To determine what
effect interfering with the function of S3RA expressed on the cell
surface might have, cells were incubated overnight with SEAM 3
at mAb concentrations used in the binding studies described
above. Under microscopic examination, the cells exhibited
characteristics of undergoing apoptosis (data not shown). Based
on this initial observation, we used two independent assays to
measure the effect of SEAM 3 on the viability of the four cell lines:
flow cytometry with the ViaCount reagent and a lactate
dehydrogenase (LDH) release assay. The first is based on
membrane permeable and impermeable DNA-binding fluorescent
dyes and the LDH assay on the release of LDH resulting from the
loss of membrane integrity. The results for the concentration-
dependent effect of SEAM 3 on the viability of the four cell lines
after 16 hours of incubation using the LDH assay are shown in
Figure 7A. Purified SEAM 3 was cytotoxic against the four cell
lines tested but the effect was variable for each cell line. Jurkat cells
were the most sensitive to SEAM 3-mediated antibody dependent
cytotoxicity (ADC) while SK-MEL-28 cells were the least sensitive.
Approximately 45% of Jurkat cells and 25% of SK-MEL-28,
CHP-134, and SH-SY5Y cells were killed at the highest SEAM 3
concentration tested. SEAM 3-mediated cytotoxicity appeared to
level off at a fixed fraction of cells. For example, ADC against
Jurkat and SH-SY5Y cells mediated by SEAM 3 approached a
maximum at about 10 mg/ml of SEAM 3 with only a marginal
increase in killing at 20 mg/ml (Figure 7A). The results may reflect
the fact that both the number of cells and the amount of S3RA
expressed by the cells was variable among the cell lines (see
Table 3) and that the amount of antigen remains relatively
constant in the population of cells over the 16 hr time period.
Results similar to those shown in Figure 7A, were obtained using
the Guava ViaCount assay (data not shown). To demonstrate
specificity of SEAM 3 ADC activity, we attempted to inhibit killing
with soluble N-Pr MBPS. However, the inhibition experiment was
confounded because soluble N-Pr MBPS was taken up by live cells
resulting in a marked increase in the expression of S3RA (B. T.
Hagen and G. R. Moe, unpublished).
SEAM 3 binding induces apoptosis in Jurkat and SK-MEL-
28 cells
To determine whether SEAM 3 cytotoxicity resulted from
apoptosis of Jurkat and SK-MEL-28 cells, we compared the effect
of SEAM 3 binding on the cells to the effect of staurosporine, a
general kinase inhibitor that is a classic inducer of apoptosis [37].
In the example shown in Figure 7B, SK-MEL 28 cells were
incubated for 12 and 24 hours with the irrelevant mAb, DMSO,
staurosporine, or SEAM 3, and the number of live, apoptotic and
dead cells was quantified using a flow cytometric assay that
measured the appearance of phosphatidylserine on the cell surface
through annexin V binding and DNA content by propidium
iodide staining. As shown in Figure 7B, treatment with SEAM 3 or
staurosporine increased the percent of apoptotic and dead cells
after 12 hrs and 24 hrs compared to the IgG2b and DMSO
controls, respectively. The results for Jurkat cells incubated with
10 mg/ml SEAM 3 were similar to those shown for SK-MEL 28
cells in Figure 7B (data not shown).
Discussion
Little is known about the expression of de-N-acetyl sialic acid-
containing antigens in normal or diseased human tissues. Studies
published to date have presented evidence for the expression of
gangliosides GM3 and GD3 containing Neu in some cancer cell
lines and Neu-containing GD3 in primary human melanoma
tumors [23,24,26]. Our laboratory has shown that NmB strains
and the protozoan parasite Leishmania major express NeuPSA
[19,20,38,39], which had not been described previously for any
organism. In this study, we have shown by IHC that the anti-
NeuOSA/PSA mAb, SEAM 3, reacts with antigens that are
expressed in normal squamous cells, melanocytes and in primary
human melanomas. The S3RA appeared to be produced at
considerably higher levels in primary melanomas compared to
normal melanocytes, suggesting the S3RA expression is abnormal
in the tumor cells. Unlike gangliosides and known polysialylated
surface proteins, such as PSA-NCAM, S3RA appeared to be
located mainly inside cells. In addition to primary tumors, S3RA
was detected in melanoma, leukemia and neuroblastoma cell lines.
Although nearly all cells in each cell line were positive for SEAM 3
binding when the cells were made permeable to the mAb by
treatment with detergent, only a subpopulation of cells ranging
from 16% to 29% of intact cells expressed S3RA on the cell
Figure 5. Absolute quantification of STX and PST mRNA of
cancer cell lines by qRT-PCR. 1 mg of total RNA from each cell line
was reverse-transcribed into cDNA, then used as the template in the
qRT-PCR reaction. The mRNA copy number of STX, PST, and GAPDH
determined from a standard curve of serially dilute standards is shown
in the graph as target mRNA copies per 10
7 GAPDH mRNA copies. Error
bars are the SEM of triplicate measurements from three independent
populations of each cell line.
doi:10.1371/journal.pone.0027249.g005
Figure 6. Relative quantification of PST mRNA in SK-MEL-28
cells treated with scrambled siRNA or PST-specific siRNA. SK-
MEL-28 cells were transiently transfected with 50 nM siRNA for 72 hours
in triplicate, then total RNA from each cell line was reverse-transcribed
into cDNA and used as the template in the qRT-PCR reaction. Relative
quantification was determined using the comparative CT method,
normalized to GAPDH mRNA.
doi:10.1371/journal.pone.0027249.g006
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reactive with SEAM 3 were rounded up and had condensed
nuclei, characteristic of dividing cells.
The majority of S3RA being located inside cells is unusual
compared to known polysialylated proteins. As far as we are
aware, the only polysialylated antigens that are located mainly
inside cells, associated with the Golgi and ER, but can also be
found on the cell surface are the a2,8 polysialyltransferases PST
and STX [8]. We found that both PST and STX mRNAs were
expressed at variable levels in the four tumor cell lines tested. In
addition, we found that transfecting SK-MEL-28 cells with PST-
specific siRNA decreased the number of cells that expressed
S3RAs. The result directly links SEAM 3 binding to the PST
polysialyltransferase. However, S3RA was also found outside of
organelles normally associated with polysialylated antigens, which
raises questions about whether S3RA is in fact a NeuOSA/PSA
derivative or an undefined epitope that depends on the expression
of PST.
While the identity and biological function of S3RA is not
known, SEAM 3 binding to S3RA resulted in antibody dependent
cytotoxic activity against the four cell lines tested by inducing
apoptosis. The ability of SEAM 3 to effect intracellular changes by
binding to antigens on the cell surface suggests that S3RA may
have some role in signal transduction. For example, NCAM is
known to modulate the activity of several receptor proteins and
modification of NCAM with PSA in turn modulates the activity of
NCAM [9].
The effects of SEAM 3 binding on the tumor cell lines described
here raise the intriguing possibility that antibodies like SEAM 3
that are elicited by NeuSia-based vaccines may be useful for the
detection, prevention or treatment of cancers that overexpress
S3RA or related antigens. Furthermore, it may be possible to
effect changes in the production of S3RA with inhibitors of PST,
STX or, possibly, the putative PSA de-N-acetylases that may be
needed to produce S3RA.
Materials and Methods
Materials
Cell culture medium along with all supplements were purchased
from UCSF Tissue Culture Facility (San Francisco, CA) except
fetal bovine serum (Gemini Bioproducts, West Sacramento, CA).
Anti-GD3 mAb R24 was purchased from Covance, Dedham, MA.
Anti-CD56 and anti-CD95 mAbs were from BioLegend, San
Diego, CA. Anti-golgin 97 mAb was from Invitrogen, Carlsbad,
California. Anti-giantin, anti-Tuba, and anti-calnexin were from
Abcam, Cambridge, MA. Irrelevant control subclass mAbs were
from Southern Biotech, Inc. Birmingham, AL. All anti-mouse
secondary antibodies conjugated with Alexa Fluor fluorochromes
were obtained from Invitrogen. Guava Viacount Reagent was
purchased from Millipore, Billerica, MA. The LDH release assay
was from Promega, Madison, WS. Vybrant Apoptosis Assay Kit
#3 was purchased from Invitrogen.
PSA derivatives
MBPS obtained as colominic acid was from Sigma-Aldrich.
Neisseria meningitidis group C capsular polysaccharide (poly a2,9 N-
acetylneuraminic acid) was a gift from Jo Anne Welsch at
CHORI. N-propionyl MBPS (N-Pr MBPS), was prepared as
described previously [19]. Partially de-N-acetylated oligosaccha-
ride derivatives were prepared from purified MBPS dimers,
trimers and tetramers (EY Laboratories, Inc., San Mateo, CA) by
combining the oligosaccharides with sodium borohydride in water
at a ratio of 10:1 (weight/weight) and incubating the reaction
mixture at ambient temperature for 18 hrs. After extensive dialysis
in water (1 kDa cut-off membrane), the solutions were lyophilized.
The oligosaccharides were analyzed by high performance anion
exchange chromatography (Dionex, Sunnyvale, CA) with pulsed
ampermetric detection (HPAC-PAD) on a CarboPac 10 column
(Dionex) in 0.1 M NaOH with a 0.1 M to 1 M gradient of
NaOAc. De-N-acetyl GD3 and GM3 were prepared and
characterized by high performance thin layer chromatography
(HPTLC) as described by Sonnenburg et al. [40]. The amount of
neuraminic acid (Neu) and N-acetylneuraminic acid (Neu5Ac) was
determined using a modified resorcinol assay described in [19].
Subsequently, we have determined that the assay is best performed
in sealed glass hydrolysis tubes (Pierce, Rockford, IL) in a boiling
water bath for 7 minutes for Neu and, separately, 30 minutes for
Neu5Ac. The Neu concentration was measured from the
absorbance at 500 nm of the colored complex in the aqueous
layer, which was compared to a standard curve generated using
several concentrations of fully de-N-acetylated colominic acid. The
results obtained using this method on partially de-N-acetylated
colominic acid containing 16%, 23%, 41%, 50%, 57%, and 79%
Neu were nearly the same as those measured on the same samples
by NMR (data not shown). Neu5Ac was determined from the
absorbance at 580 nm of the alcohol layer and compared to a
standard curve based on unmodified colominic acid.
Inhibition ELISA
Inhibition of SEAM 3 binding to a solid phase dodecylamine
derivative of N-Pr MBPS was performed as previously described
[18,19].
Tissue Culture
SK-MEL-28 human melanoma cells were purchased from
ATCC (HTB-72). Cells were grown routinely in RPMI 1640
medium containing 0.1 mM non-essential amino acids, 1.0 mM
sodium pyruvate, 2 mM glutamine, penicillin/streptomycin and
10% fetal bovine serum (FBS) at 37uCi n5 %C O 2. Confluent cells
Table 4. Effect of polysialyltransferase PST siRNA on SEAM 3 binding to SK-MEL-28 cells.




Scrambled PST siRNA PST siRNA
1 (1) 80 42 NA
2( 3 ) 8 2 60.6 7462 0.02
3( 3 ) 8 2 60.4 5960.7 ,0.0001
aBinding to Triton X-100-treated SK-MEL-28 cells 72 hours after transfection with the indicated siRNA was measured by flow cytometry as shown in Figure3 .
bP values comparing the mean percentages of SEAM 3-positive cells were determined using an unpaired two tailed t test.
doi:10.1371/journal.pone.0027249.t004
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Trypsin/0.53 mM EDTA solution, triturating to release adherent
cells and washing in media before re-seeding into new growth
medium. SK-MEL-28 cells were only used up to passage 10 from
the original ATCC stock of cells. Jurkat cell clone E6-1, a human
acute lymphoblastic leukemia T cell line was purchased from
ATCC (TIB-152). Jurkat cells were grown in the same media as
SK-MEL-28 cells in 5% CO2 at 37uC and subcultured every 3
days with a split ratio of about 1:5. CHP-134 and SH-SY5Y,
human neuroblastoma cell lines were originally purchased from
the European Collection of Cell Cultures (ECACC) and ATCC
(CRL-2266), respectively. CHP-134 cells were routinely grown in
RPMI 1640 medium containing 0.1 mM non-essential amino
acids, 1.0 mM sodium pyruvate, 2 mM glutamine, penicillin/
streptomycin and 10% FBS at 37uCi n5 %C O 2. Confluent cells
were sub-cultured (1:3 to 1:5). The cells were released from the
plate with repeated pipetting then re-seeded into new growth
medium. SH-SY5Y cells were routinely grown in DMEM/F12
50% mix medium containing penicillin/ streptomycin and 10%
FBS at 37uCi n5 %C O 2. Confluent cells were sub-cultured (1:3 to
1:5) by treating with 0.25% (w/v) Trypsin/0.53 mM EDTA
solution, triturating to release adherent cells and washing in media
before re-seeding into new growth medium.
Immunohistochemistry
Unfixed frozen and formalin fixed paraffin-embedded samples
were either prepared locally from tissues obtained under an IRB
approved protocol from the National Disease Research Inter-
change (normal skin and primary human melanoma) or
purchased from USBiomax (human melanoma arrays). Formalin
fixed paraffin-embedded tissues were deparaffinized in xylene,
and then rehydrated in a series of 95%, 90%, 75%, and 50%
alcohol incubations. Antigen retrieval was conducted using a
Decloaking Chamber (BioCare Medical) and Reveal Decloaker
(BioCare). Unfixed or frozen sections were stained using a
Nemesis 3600 (BioCare) automated stainer and IntelliPATH
FLX Universal HRP Detection Kit (BioCare). Samples were
blocked for 5 minutes with peroxidase block, incubated for
1 hour with 0.5 mg/ml IgG2b, SEAM 3, IgG3, or anti-GD3 mAb
R24 primary antibody, 20 minutes with secondary, 20 minutes
with tertiary antibody, 5 minutes with 3, 39 diaminobenzidine
(DAB), and finally counterstained with hemotoxylin. All slides
were analyzed using a Zeiss Axioplan 2 Upright Light/
Fluorescence Microscope with digital video capture. Digital
images were obtained using Q Capture (Technical Instruments,
San Jose, CA).
mAb Binding Assay
Adherent cells were detached from the flask with either 0.25%
(w/v) Trypsin/0.53 mM EDTA (SK-MEL-28 and SH-SY5Y) or
pipetting (CHP-134) before being collected into a 96-round
bottom well plate. Non-adherent Jurkat cells were directly
collected into wells of a 96-round bottom well plate. Cells were
counted and viability was determined using Guava Viacount
Reagent and Guava EasyCyte capillary flow cytometer (Milli-
pore). Cells used consistently had greater than 90% viability.
Approximately 10
5 cells per well were spun at 5006gf o r
5 minutes and washed with ice cold Dulbecco’s phosphate
buffered saline (D-PBS) without Mg
2+ or Ca
2+ salts (CMF D-
PBS). Cell surface binding was determined using live cells.
Intracellular binding was determined using fixed, Triton X-100
treated cells. Cells were fixed with ice-cold 0.37% (v/v)
formaldehyde in PBS for 15 minutes. Cells were pelleted by
centrifugation as above and incubated in 0.05% (w/v) Triton
Figure 7. SEAM 3 mediates antibody dependent cytotoxicity
by inducting apoptosis. (A), Antibody dependent cytotoxicity of
SEAM 3 against SK-MEL-28, CHP-134, SH-SY5Y, and Jurkat cells as
measured by LDH release assay. Each cell line was incubated with
increasing concentrations of SEAM 3 for 16 hrs. LDH release was
measured and percent cytotoxicity was determined using spontaneous
release and maximal release following treatment with Triton X-100. (B),
Analysis of SEAM 3 mediated apoptosis against SK-MEL-28 melanoma
cells by flow cytometry. SK-MEL-28 cells were incubated with an
irrelevant IgG2b mAb (5 mg/ml), DMSO, 0.1 mM Staurosporine, or 5 mg/
ml SEAM 3 for 12 or 24 hours. Cells were then stained with fluorescently
labeled annexin V and propidium iodide and the fraction of live (open
bars), apoptotic (cross-hatched bars), and dead cells (black bars) was
measured by flow cytometry.
doi:10.1371/journal.pone.0027249.g007
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5 mg/ml primary antibody diluted in 3% goat serum for 1 hour
at room temperature. Cells were washed by pelleting and
resuspending three times with ice-cold CMF D-PBS, and then
secondary goat anti-mouse antibody conjugated to a specific
fluorochrome was applied for at least 30 min at 4uC in the dark.
The cells were washed three additional times then binding was
analyzed using the Guava EasyCyte flow cytometer (Millipore).
Negative control samples were treated with a subclass-matched
irrelevant antibody, which were used to determine baseline
fluorescence. Positive controls for each cell type were anti-CD3
for Jurkat cells, anti-GD3 (R24) for SK-MEL-28 cells, and anti-
NCAM (CD56) for CHP-134 and SH-SY5Y cells. FlowJo
(TreeStar) was used for data analysis.
Laser scanning confocal microscopy
The preparation of slides and acquisition of images was
performed by C. Paul Plested from CHORI or by L.M.S. CHP-
134 or SK-MEL-28 cells (,10
5) were cultured on multi-well
microscope slides that had been treated with poly-L-lysine (Nunc,
ThermoFisher Scientific). After an overnight incubation cells were
gently washed with PBS and fixed with ice-cold 1% (v/v)
formaldehyde in PBS. After 20 minutes, the cells were washed
with PBS before being blocked in a solution of 3% (v/v) goat
serum without or with 0.05% (w/v) Triton X-100 for 1 hour. The
primary antibodies were added and incubated for 2 hours at
ambient temperature or overnight at 4uC. The primary antibodies
included anti-NeuPSA mAb SEAM 3 [18], anti-PSA 2-1-B [31],
anti-CD56 (Sigma), anti-GD3 and R24 (Covance). Cells were
gently washed as described above with ice-cold PBS before goat
anti-mouse isotype-specific secondary antibodies conjugated to
Alexa Fluor 488, Alexa Fluor 546, or Alexa Fluor 633 were
applied for at least 1 hour at 4uC in the dark. After another series
of gentle washes, a hardening mounting medium containing DAPI
was applied (VECTASHIELD, Vector Labs).
Subcellular localization of SEAM 3 to the ER was determined
using anti-calnexin (Abcam) and to the Golgi using anti-giantin
(Abcam), anti-golgin 97 (Invitrogen) and anti-Tuba (Abcam).
SK-MEL-28 cells were grown on coverslips overnight in their
normal growth media. The next day, cells were briefly rinsed with
PBS, then fixed with 4% paraformaldehyde for 15 minutes at
room temperature. Cells were washed twice for 5 minutes with
PBS, treated with 0.2% Triton X-100 for 10 minutes, then washed
with PBS three times for 5 minutes. Next, cells were blocked in 1%
BSA/PBST containing 0.3 M glycine for 30 minutes, followed by
incubation with primary antibody in 1% BSA/PBST. After one
hour, cells were washed three times with PBS, then incubated for
30 minutes with secondary antibody in 1% BSA. Cells were
washed three times with PBS. Nuclei were stained using 0.5 ug/ml
Hoechst 33258 (Invitrogen) for 1 minute, rinsed with PBS, then
the coverslips were mounted to slides using Prolong Antifade
(Invitrogen). Confocal images were obtained using a Zeiss
Meta510 (The Biological Imaging Facility, University of Califor-
nia, Berkeley, CA) or Zeiss LSM710 (CHORI) laser scanning
confocal microscopes and were analyzed using ImageJ Software
[41] and colocalization with JACoP [35]. Control antibodies and
secondary antibodies applied alone were routinely used to assess
background fluorescence.
Quantitative Real-Time PCR
RNA was isolated from SH-SY5Y, CHP-134, SK-MEL-28 and
Jurkat cells using an RNeasy Mini Kit (Qiagen). Cells were lysed
using a 20-gauge needle. RNA purity and quantity was analyzed
using a Thermo Scientific Nanodrop spectrophotometer. One mg
of RNA was reverse transcribed using Qiagen’s Omniscript RT
Kit to synthesize cDNA. 2 ml of cDNA was mixed with Taqman
Gene Expression Master Mix, and the appropriate pre-designed
Taqman primer/probe mixture (Invitrogen). The cDNA was
amplified using an ABI 7500 Fast Real Time PCR System
(Applied Biosystems). Absolute quantification of GAPDH, STX,
and PST mRNA for each sample was determined using standard
curves generated using serially diluted standards containing the
same sequence as the amplicon. Absolute quantity is expressed as
copies of target gene/10
7 copies GAPDH.
siRNA transfection and analysis
SK-MEL-28 cells were grown to approximately 80% con-
fluency overnight. siRNA was mixed with Lipofectamine RNAi-
MAX (Invitrogen) and prepared according to the manufacturer’s
instructions. 50 nM of either Silencer Select negative control #1
(Invitrogen) or Silencer Select ST8Sia4 (Invitrogen) was reverse
transfected into the cells and incubated for 72 hours at 37uC. After
72 hours, gene knock-down was determined by real-time qPCR.
RNA was processed and cDNA was amplified as above, then
relative quantity was determined by comparing to GAPDH
mRNA. NeuPSA expression was determined using flow cytometry
by comparing SEAM 3 binding as described above in the negative
control to the PST knock-down cells.
Cell Viability/Cytotoxicity Studies
Cells (,10
5 per well) were plated onto a flat bottom 96-well
tissue culture plate and incubated in their normal growth media
with IgG2b irrelevant isotype control, SEAM 3, anti-CD95, anti-
GD3, or staurosporine at 37uC for 16 or 24 hours. Cell viability
was determined after 24 hours using ViaCount Reagent, as per
manufacturer’s instructions. Briefly, adherent cells were released
from the tissue culture plate as described above. Cells in
suspension and adherent cells were collected by centrifugation
and resuspended in ViaCount Reagent. The viability was analyzed
using a pre-set program on the Guava EasyCyte flow cytometer.
Cytotoxicity was, alternatively, determined using CytoTox 96
Non-Radioactive Cytotoxicity Assay (Promega). In this assay cells
were incubated with media to determine spontaneous LDH
release, Lysis Solution to determine maximum LDH release, or
SEAM 3 for 16 hours at 37uC, then the supernatant was collected
and incubated with Substrate Mix for 30 minutes, the reaction was
stopped using Stop Solution, and the absorbance at 490 nm was
read using a SpectraMax 340PC384 microplate reader. Using the
absorbances determined, the following equation was used to
calculate percent cytotoxicity:
% cytotoxicity
~ Experimental{Spontaneous ðÞ =Maximum{ Spontaneous ðÞ ðÞ | 100
Apoptosis Assay
Cells (,10
5 per well) were plated onto a flat bottom 96-well
tissue culture plate and incubated in their normal media
containing IgG2b (5 mg/ml), SEAM 3 (5 mg/ml), DMSO or
0.1 mM staurosporine at 37uC for 12 or 24 hours. Using a
Vybrant Apoptosis Assay Kit #3 (Invitrogen) cells were stained
with FITC Annexin V and propidium iodide according to the
manufacturer’s instructions. Binding was determined using the
Guava EasyCyte flow cytometer and the data analyzed using
FlowJo (TreeStar).
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